![Careers in Discovery](https://pbcdn1.podbean.com/imglogo/image-logo/18676005/1478977-1674819143110-a9f40d319527c.jpg)
1K
Downloads
134
Episodes
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
Episodes
![Samantha Bailey-Bucktrout, Akamis Bio](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/63f38d6f10c7137b246a5bfad5cd4361_300x300.jpg)
Wednesday Nov 29, 2023
Samantha Bailey-Bucktrout, Akamis Bio
Wednesday Nov 29, 2023
Wednesday Nov 29, 2023
"I see all the other element of my current role - the leadership, management and mentoring - as enabling the science."
Samantha Bailey-Bucktrout is the Senior Vice President of Research at Akamis Bio, a company harnessing the power of tumour gene therapy in the fight against cancer.
Samantha talked to us about her career in cancer immunotherapy, what Greek mythology has to do with modern-day Biotech, and the importance of a collaborative approach to drug development.
Enjoy!
![Beverley Carr, Amphista Therapeutics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/48b5f4479396df1145517da816c7f82b_300x300.jpg)
Wednesday Nov 08, 2023
Beverley Carr, Amphista Therapeutics
Wednesday Nov 08, 2023
Wednesday Nov 08, 2023
"You can learn corporate finance. You can do Excel modelling. You can read books on negotiation. But I strongly believe that Business Development is an art, and it's something that you can only really learn by doing."
Beverley Carr is the Chief Business & Operating Officer of Amphista Therapeutics, a company re-engineering TPD therapies to tackle cancer and neurological disorders.
Beverley joined us on Careers in Discovery to talk about how Amphista are tackling the limitations of first-generation TPDs, why strategic Business Development is coming back into fashion, and the qualities that make a good BD person.
Enjoy!
![Janette Thomas, Five Alarm Bio](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/5036ce1eab3995ec712c30af8348e243_300x300.jpg)
Wednesday Oct 25, 2023
Janette Thomas, Five Alarm Bio
Wednesday Oct 25, 2023
Wednesday Oct 25, 2023
"I realised that drug development was much more than just research. There's a huge amount of work beyond coming up with a molecule, but research scientists just don't get exposed to it."
Janette Thomas has built a career from Researcher to Project Manager, Operations Director and now CEO of Five Alarm Bio, a company focused on novel approaches to anti-aging.
Janette joined us to talk about the current state of anti-aging research, what makes a good project manager and why you should never be limited by fear in your career.
Enjoy!
![Dan Williams, SynaptixBio](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/25cde5f566c98cc5fb3499eea81e19b5_300x300.jpg)
Wednesday Oct 04, 2023
Dan Williams, SynaptixBio
Wednesday Oct 04, 2023
Wednesday Oct 04, 2023
"If you've got into science because science itself motivates you, try and stay with it. Do other things too, learn what you need to, but be careful not to leave that science behind."
Dan Williams is the CEO of SynaptixBio, a company dedicated to developing lifesaving therapies for severe leukodystrophies.
Dan joined us to talk about the challenges of building a company around an ultra rare disease, why exposure to an executive team is critical for career development and what REALLY makes early stage Biotech companies successful.
Enjoy!
![Matthew Duchars, CHAIN Biotech](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/075222ac909a61c3c4859c8da025e05b_300x300.jpg)
Wednesday Sep 27, 2023
Matthew Duchars, CHAIN Biotech
Wednesday Sep 27, 2023
Wednesday Sep 27, 2023
"Taking a vaccine from concept and early stage data through to a licensed product that you're putting into millions of people takes 10-15 years on average, but it was done in 10 months. So how did we manage to acheive that? Nobody wanted to be stuck in lockdown forever and so everyone really focused on coming together - a combination of industry, government and academia, all focused on how to [deliver this vaccine] on the shortest possible time, safely and effectively."
Matthew Duchars is the CEO of CHAIN Biotech, a fascinating company developing oral vaccines and immunotherapies that target the microbiome.
Matthew joined us to discuss the importance of culture and environment in delivering great science, how a career in vaccine development was set into motion by an encounter with a dead mole, and being at the heart of the UK vaccines ecosystem during the COVID pandemic.
Enjoy!
![Orla Cunningham, Granular Therapeutics & Ultrahuman 8](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/c75a6250f90714d500ee5b122625deae_300x300.jpg)
Wednesday Sep 13, 2023
Orla Cunningham, Granular Therapeutics & Ultrahuman 8
Wednesday Sep 13, 2023
Wednesday Sep 13, 2023
"Whatever opportunity arises, it may not be on the path that you think you should be on, but it will bring value. You have to do your best to identify what that value is. So keep an open mind about opportunities - there's sometimes value in applying for something that you only have 30% of the requirements for."
Orla Cunningham is the Chief Scientific Officer of Granular Therapeutics and Ultrahuman 8, companies developing novel single antibody therapies for a range of diseases.
Orla talked to us about her fascinating career to date, as well as the therapeutic potential of mast cells, how to get the best from your CRO partners and why communication is the most important skill scientists must develop.
Enjoy!
![Rebecca Godfrey, ExpressionEdits](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/5b1ac43b1056fb499ff953d659557335_300x300.jpg)
Wednesday Aug 16, 2023
Rebecca Godfrey, ExpressionEdits
Wednesday Aug 16, 2023
Wednesday Aug 16, 2023
"LinkedIn is like the professional Instagram. It looks like people's careers were so easy, mapped out and planned. It doesn't tell of the difficult decisions, the failures, the challenges, the dead ends and having to start again."
Rebecca Godfrey is the Chief Operating Officer of ExpressionEdits and the author of "The Leadership Vaccine".
Rebecca talked to us on Careers in Discovery about her journey from Immunology PhD to COO, figuring out who you are professionally and why she loves her job.
Enjoy!
![Jenny Barnett, Monument Therapeutics & Five Lives](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/034d5423c1713e1a81adcef42f43b987_300x300.jpg)
Wednesday Aug 09, 2023
Jenny Barnett, Monument Therapeutics & Five Lives
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
"Cancer drugs only started working once we realised that we actually had to measure what was going on in the tumour and match them appropriately [to patients]...we're just on the cusp of that approach being accepted in neuroscience."
Jenny Barnett is the CEO of Monument Therapeutics, a Biotech company using precision medicine approaches to develop new treatments for psychiatric and neurological conditions, and the Chief Scientific Officer of Five Lives, a digital therapeutics business focused on reducing dementia risk.
Jenny joined us on Careers in Discovery to discuss her career so far, why academia wasn't for her, how digital biomarkers can improve clinical trial performance and the things she had to learn to become an effective CEO.
Enjoy!
![Image](https://pbcdn1.podbean.com/fs1/user-site-dist/assets/customize-component4.png)
Your Title
This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.